Emerging Gene Therapy Start-Ups
“Gene therapies have proven to deliver transformational benefit to patients who suffer from devastating diseases with significant, unmet medical need.” Lexeo Therapeutics is entering the market with $85 million, 18 gene therapy programs spanning from rare and more prevalent monogenic diseases, and an impressive team. Ronald Crystal, a gene therapy veteran founded Lexeo Therapeutic with …